Compliance Rate
Compliance Rate
36.36%
Compliant submissions
8
Incompliant submissions
14
Total trials
22
My Organizations' Clinical Trials
Showing 1575 of 1641 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/18
End: 09/30/20
Due: 09/30/21
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 12/07/18
End: 07/28/21
Due: 07/28/22
Phase: N/A
Priority: Normal
Start: 07/01/16
End: 06/30/18
Due: 06/30/19
Phase: N/A
Priority: Normal
Start: 03/26/24
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 04/30/17
Due: 04/30/18
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 11/01/26
Due: 11/01/27
Phase: N/A
Priority: Normal
Start: 03/27/19
End: 01/17/20
Due: 01/17/21
Phase: N/A
Priority: Normal
Start: 07/12/23
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 07/27/23
End: 08/11/23
Due: 08/11/24
Phase: N/A
Priority: Normal
Start: 10/09/19
End: 12/01/25
Due: 12/01/26
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 05/07/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 04/01/13
End: 08/31/18
Due: 08/31/19
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 10/30/18
End: 06/02/22
Due: 06/02/23
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 10/31/14
Due: 10/31/15
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 10/15/18
End: 06/11/20
Due: 06/11/21
Phase: N/A
Priority: Normal
Start: 12/23/19
End: 05/11/23
Due: 05/11/24
Phase: N/A
Priority: Normal
Start: 10/22/24
End: 01/28/28
Due: 01/28/29
Phase: N/A
Priority: Normal
Start: 10/31/12
End: 10/31/14
Due: 10/31/15
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 06/30/11
Due: 06/30/12
Phase: N/A
Priority: Normal
Start: 07/07/21
End: 06/30/23
Due: 06/30/24